In our comparison series on weight loss medications, we compare different treatment options and explain how they differ from a medical perspective. This article focuses on Wegovy vs. Saxenda: two GLP-1-based medications for medical weight management.
Both medications can influence hunger, satiety and body weight. However, there are important differences: Wegovy contains semaglutide and is classically injected once weekly. Saxenda contains liraglutide and is injected daily.
The question “Wegovy or Saxenda?” cannot be answered based on the active ingredient alone. Effectiveness, everyday use, tolerability, comorbidities, treatment goals and medical assessment are all important. Studies show that semaglutide can lead to greater average weight loss than liraglutide. Nevertheless, Saxenda may still be relevant in certain situations.
Table of Contents
- Wegovy vs. Saxenda: Quick Comparison
- The Most Important Difference: Semaglutide vs. Liraglutide
- What Is Wegovy?
- What Is Saxenda?
- How Do Wegovy and Saxenda Work?
- Which Medication Leads to More Weight Loss?
- Everyday Use: Weekly vs. Daily
- Side Effects and Safety
- Update: What Does the Wegovy Pill Mean?
- Wegovy or Saxenda: Which Is Suitable for Whom?
- How Does Saxenda Compare With Other Weight Loss Medications?
- Medically Supervised Weight Loss at The Body Clinic
- Conclusion
- Frequently Asked Questions
Wegovy vs. Saxenda: Quick Comparison
Wegovy and Saxenda both belong to the group of GLP-1 receptor agonists. They are used for medical weight management, but they differ clearly in active ingredient, use and average weight loss.
| Aspect | Wegovy | Saxenda |
|---|---|---|
| Active ingredient | Semaglutide | Liraglutide |
| Medication class | GLP-1 receptor agonist | GLP-1 receptor agonist |
| Use | Classically once weekly as a subcutaneous injection. | Once daily as a subcutaneous injection. |
| Treatment goal | Weight reduction and long-term weight management. | Weight reduction and weight management. |
| Duration of action in everyday life | Longer duration of action, therefore weekly use. | Shorter duration of action, therefore daily use. |
| Weight loss in direct comparison | In STEP 8, greater average weight loss than with liraglutide. | In STEP 8, lower average weight loss than with semaglutide 2.4 mg. |
| Current update | An oral Wegovy formulation was recommended by the EMA for approval extension in 2026. | Saxenda is administered as a daily liraglutide injection. |
The Most Important Difference: Semaglutide vs. Liraglutide
The most important difference between Wegovy and Saxenda lies in the active ingredient. Wegovy contains semaglutide. Saxenda contains liraglutide.
Both active ingredients belong to the group of GLP-1 receptor agonists. They mimic the effect of the body’s own hormone GLP-1 and can therefore influence appetite, satiety, gastric emptying and blood glucose regulation.
The key practical difference: semaglutide in Wegovy is classically used once weekly, while liraglutide in Saxenda is used daily. This affects everyday routine, missed doses and personal preferences.
What Is Wegovy?
Wegovy is a prescription medication containing the active ingredient semaglutide. It is used for weight management in suitable patients. Treatment is used in addition to a reduced-calorie diet and increased physical activity.
Wegovy may be suitable for adults with obesity or overweight with at least one weight-related comorbidity. These may include type 2 diabetes, high blood pressure, abnormal blood lipid levels, sleep apnea or cardiovascular disease.
Wegovy is mainly known as a weekly injection. In addition, an oral Wegovy formulation was recommended by the EMA for approval extension in 2026. You can find more information on our page about the Wegovy pill.
What Is Saxenda?
Saxenda is a prescription medication containing the active ingredient liraglutide. It is also used for weight management when certain medical requirements are met. Saxenda is also used in addition to nutrition and physical activity.
Liraglutide also belongs to the group of GLP-1 receptor agonists. However, the active ingredient has a shorter duration of action than semaglutide. This is why Saxenda is not injected weekly, but daily.
Saxenda is not a lifestyle product, but a medication for medically justified treatment situations. Whether it is suitable should be assessed individually by a doctor.
How Do Wegovy and Saxenda Work?
Wegovy and Saxenda both act through GLP-1 signaling pathways. This means they can influence certain processes that are important for hunger, satiety, energy intake and blood glucose regulation.
| Effect Aspect | Wegovy | Saxenda |
|---|---|---|
| GLP-1 effect | Semaglutide activates GLP-1 receptors. | Liraglutide activates GLP-1 receptors. |
| Appetite | Hunger and food cravings may decrease. | Hunger and food cravings may also decrease. |
| Satiety | Satiety may occur earlier and last longer. | Satiety may also occur earlier. |
| Gastric emptying | May be slowed. | May also be slowed. |
| Blood glucose | Supports glucose-dependent insulin release. | Also supports glucose-dependent insulin release. |
Both medications can therefore help patients feel less hungry, become full sooner and eat smaller portions. This can create a calorie deficit, which leads to weight loss.
Which Medication Leads to More Weight Loss?
The question of greater weight loss is one of the most important differences between Wegovy and Saxenda. In direct study data, semaglutide 2.4 mg performed better than liraglutide 3.0 mg.
In the STEP 8 trial, once-weekly semaglutide 2.4 mg and once-daily liraglutide 3.0 mg were directly compared in adults with overweight or obesity without diabetes. After 68 weeks, average weight loss was significantly greater with semaglutide than with liraglutide.
| Study Aspect | Semaglutide 2.4 mg | Liraglutide 3.0 mg |
|---|---|---|
| Direct comparison | STEP 8 directly investigated semaglutide against liraglutide. | Liraglutide was the comparator treatment. |
| Duration | 68 weeks. | 68 weeks. |
| Use | Once weekly. | Once daily. |
| Average weight change | About minus 15.8 percent. | About minus 6.4 percent. |
These data support stronger average weight loss with Wegovy. However, this does not mean that Wegovy is automatically the best choice for every person. Studies show averages. In everyday life, tolerability, pre-existing conditions, side effects, costs, availability, practicality and personal treatment goals also matter.
Weight loss should also not be assessed only by kilograms. Safe treatment also takes muscle mass, nutrition, side effects, eating structure and long-term weight stabilization into account. You can find more on this in the article Preserving Muscle Mass Despite a Calorie Deficit.
Everyday Use: Weekly vs. Daily
A major practical difference between Wegovy and Saxenda lies in how often they are used. Wegovy is classically injected once per week, while Saxenda is injected daily.
For many patients, weekly use is easier in everyday life. It can be integrated into a fixed weekly routine. Daily use, on the other hand, may require more attention, but it can also provide a very regular structure for some people.
| Everyday Question | Wegovy | Saxenda |
|---|---|---|
| How often? | Once weekly. | Once daily. |
| How? | Subcutaneous injection. | Subcutaneous injection. |
| Dose escalation? | Gradual increase according to a medical schedule. | Gradual increase according to a medical schedule. |
| Everyday routine | A fixed weekday may be enough. | Daily reminder and routine required. |
| Tablet option? | An oral Wegovy formulation was recommended by the EMA for approval extension in 2026. | Saxenda is known as a daily injection. |
Important: use should not be changed independently. Anyone who has side effects, can barely eat, vomits repeatedly or feels unsure should have the therapy medically reviewed.
Side Effects and Safety
Wegovy and Saxenda can cause similar side effects because both act through GLP-1 signaling pathways. Gastrointestinal symptoms are particularly common.
These include nausea, vomiting, diarrhea, constipation, abdominal pain or fullness. Such symptoms often occur at the beginning of treatment or after dose increases. They are often mild to moderate, but severe or persistent symptoms should be medically assessed.
| Topic | Possible Meaning | What Matters |
|---|---|---|
| Nausea and fullness | Satiety and gastric emptying change. | Small portions, eating slowly, reducing very fatty meals. |
| Diarrhea or constipation | Digestion, fluids, fiber and food volume change. | Drink enough, increase fiber slowly and monitor symptoms. |
| Eating too little | Reduced hunger can lead to skipped meals. | Plan protein, energy and nutrients consciously. |
| Muscle loss | With significant weight loss, lean mass may also be lost. | Consider protein, strength training and follow-up. |
| Independent switch | Switching or combining without supervision can increase risks. | No self-medication, no independent switching, no combination without medical supervision. |
Practical guidance on nutrition during therapy can be found in our article on the Do’s and Don’ts of nutrition during medication-assisted weight loss. We explain why eating too little during GLP-1 therapy can become problematic in the article What if I Eat Too Little During Therapy?.
Update: What Does the Wegovy Pill Mean?
A current difference concerns the dosage form. Wegovy has so far mainly been known as a weekly injection. In May 2026, however, the EMA recommended an approval extension for an oral Wegovy formulation.
This Wegovy pill would be an oral alternative to the injection for adults with obesity or overweight with at least one weight-related comorbidity. It would still be prescription-only and would need to be taken according to medical instructions.
For the comparison with Saxenda, this means: Wegovy could also become relevant as a pill in the future, while Saxenda is still classified as a daily injection. Whether and when a tablet form actually becomes suitable in everyday life depends on approval, availability, price, reimbursement and individual suitability.
You can find more information on our page about the Wegovy pill and in our article on the future of weight loss medications.
Wegovy or Saxenda: Which Is Suitable for Whom?
The question “Wegovy or Saxenda?” should not be answered based only on average weight loss. Wegovy may be more effective on average and is often easier in everyday life because it is used weekly. Still, Saxenda may play a role depending on the individual situation.
| Situation | Possible Interpretation | Important |
|---|---|---|
| Greater average weight loss is the main priority | Wegovy may be particularly relevant based on study data. | Individual suitability, tolerability and risks must be assessed. |
| Weekly use is preferred | Wegovy may be easier in everyday life. | A fixed weekly routine and correct use are important. |
| A daily routine is considered helpful | Saxenda may provide structure for some people. | Daily use must be followed consistently. |
| Fear of injections or wish for an oral option | The Wegovy pill could become relevant in the future. | Availability, administration requirements and suitability should be medically assessed. |
| Side effects or very low food intake | Treatment should be reviewed and adjusted if necessary. | Do not pause, switch or adjust the dose independently. |
It is also important that Wegovy and Saxenda should not be used together or exchanged independently. Any switch should only be planned by a doctor.
How Does Saxenda Compare With Other Weight Loss Medications?
Saxenda is one of the established GLP-1-based medications for weight loss, but it is used differently in everyday life than many newer options. While Saxenda is injected daily, Wegovy and Mounjaro are classically used once weekly. Anyone who mainly wants to compare everyday use may therefore find our article on weekly and daily weight loss injections helpful.
When it comes to how semaglutide compares with other active ingredients, our overview of semaglutide medications can provide useful orientation. For patients comparing newer treatment options, the articles Wegovy vs. Mounjaro and Mounjaro vs. Saxenda may also help with the next step.
Medically Supervised Weight Loss at The Body Clinic
At The Body Clinic, medically supervised weight loss is the focus. This means that a medication is not viewed in isolation, but in connection with health status, treatment goal, nutrition, physical activity, side effects and long-term stabilization.
If Wegovy, Saxenda, Mounjaro or other options may be suitable, we assess which therapy makes medical sense. You can find an overview of possible treatment options on our page about medication for weight loss.
Especially with GLP-1 medications, accompanying guidance remains important. We explain why nutrition continues to play a central role despite medication in the article Why GLP-1 Needs Guidance.
If you would like to check whether medical weight loss may generally be suitable for you, you can check your eligibility for medical weight loss. Information on potential costs can be found on our page about the costs of medical weight loss.
Conclusion
Wegovy and Saxenda are both GLP-1-based medications for medical weight management, but they differ clearly. Wegovy contains semaglutide and is classically used once weekly. Saxenda contains liraglutide and is used daily.
In direct study data, semaglutide 2.4 mg led to greater average weight loss than liraglutide 3.0 mg. This makes Wegovy a particularly relevant option for many patients, but it does not mean that every decision must automatically favor Wegovy.
Medical suitability, pre-existing conditions, tolerability, side effects, everyday life, nutrition, physical activity and long-term support are decisive. Anyone weighing Wegovy against Saxenda should therefore have the decision assessed medically.
Frequently Asked Questions
What Is the Difference Between Wegovy and Saxenda?
Wegovy contains semaglutide and is classically injected once weekly. Saxenda contains liraglutide and is injected daily. Both belong to the group of GLP-1 receptor agonists.
Is Wegovy Stronger Than Saxenda?
In direct study data, semaglutide 2.4 mg led to greater average weight loss than liraglutide 3.0 mg. However, the individual effect can vary.
What Is Better: Wegovy or Saxenda?
This cannot be answered in general terms. Wegovy may be more effective on average and is used weekly. Saxenda may still be relevant depending on the individual situation. The decision should be made medically.
Can You Switch From Saxenda to Wegovy?
A switch should never be made independently. If a switch appears medically appropriate, it must be planned by a doctor so that dosage, tolerability, indication and possible risks are considered.
Can Wegovy and Saxenda Be Used Together?
No, independent combination is not intended and may increase risks. Wegovy and Saxenda should not be used at the same time unless a doctor makes a specific medical decision.
Do Wegovy and Saxenda Have Similar Side Effects?
Yes, many possible side effects are similar, especially gastrointestinal symptoms such as nausea, vomiting, diarrhea, constipation or abdominal pain. Severity and frequency can vary individually.
Are Wegovy or Saxenda Available as Tablets?
Wegovy is mainly known as an injection. In May 2026, the EMA recommended an approval extension for a Wegovy pill. Saxenda is known as a daily injection.
Which Medication Is Better for Me?
That depends on BMI, comorbidities, previous treatments, tolerability, side effects, everyday routine, costs, availability and treatment goal. A medical eligibility assessment is therefore decisive.
Sources
- Wegovy EPAR, European Medicines Agency
- Saxenda EPAR, European Medicines Agency
- Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes, JAMA
- STEP 8 Randomized Clinical Trial, PubMed
- EMA: First oral GLP-1 treatment for weight management
- Wegovy EPAR Product Information, European Medicines Agency
- Saxenda EPAR Product Information, European Medicines Agency